Cargando…
Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
Regulatory T cells (Tregs) are key mediators of peripheral self-tolerance and alterations in their frequencies, stability, and function have been linked to autoimmunity. The antigen-specific induction of Tregs is a long-envisioned goal for the treatment of autoimmune diseases given reduced side effe...
Autores principales: | Serr, Isabelle, Drost, Felix, Schubert, Benjamin, Daniel, Carolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341764/ https://www.ncbi.nlm.nih.gov/pubmed/34367177 http://dx.doi.org/10.3389/fimmu.2021.712870 |
Ejemplares similares
-
Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies
por: Serr, Isabelle, et al.
Publicado: (2021) -
Regulation of T Follicular Helper Cells in Islet Autoimmunity
por: Serr, Isabelle, et al.
Publicado: (2018) -
Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges
por: Pacella, Ilenia, et al.
Publicado: (2019) -
Opportunities for Treg cell therapy for the treatment of human disease
por: Bluestone, Jeffrey A., et al.
Publicado: (2023) -
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
por: Mukhatayev, Zhussipbek, et al.
Publicado: (2020)